Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005.

Topical photodynamic therapy (PDT) is used to treat nonmelanoma skin cancers, such as actinic keratoses, Bowen's disease, and basal cell carcinoma (superficial and nodular). This article presents up-to-date, practical, evidence-based recommendations on the use of topical PDT using 5-aminolevulinic acid or methyl aminolevulinate for the treatment (and prevention) of nonmelanoma skin cancers. A systematic literature review was conducted (using MEDLINE), and recommendations were made on the basis of the quality of evidence for efficacy, safety/tolerability, cosmetic outcome, and patient satisfaction/preference. Topical PDT is highly effective in the treatment of actinic keratoses, Bowen's disease, superficial and thin nodular basal cell carcinomas, with cosmesis typically superior to that achieved with existing standard therapies. PDT may also be a means of preventing certain nonmelanoma skin cancers in immunosuppressed patients.

[1]  A. Green,et al.  Changing patterns in incidence of non-melanoma skin cancer. , 1992, Epithelial cell biology.

[2]  M. Thissen,et al.  SHORT COMMUNICATIONPhotodynamic therapy with delta‐aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique , 2000, The British journal of dermatology.

[3]  Q. Peng,et al.  Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. , 2001, Journal of photochemistry and photobiology. B, Biology.

[4]  M. Landthaler,et al.  Photodynamic therapy in dermatology – an update , 2005, Photodermatology, photoimmunology & photomedicine.

[5]  N. Bendsoe,et al.  Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial , 2001, The British journal of dermatology.

[6]  Barbara A Gilchrest,et al.  A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. , 2004, Archives of dermatology.

[7]  D. Kessel,et al.  An apoptotic response to photodynamic therapy with endogenous protoporphyrin in vivo. , 1996, Journal of photochemistry and photobiology. B, Biology.

[8]  R. Dummer,et al.  Topical photodynamic therapy in the treatment of actinic keratoses and Bowen’s disease in transplant recipients , 2004, Transplantation.

[9]  M. Alpsten,et al.  Treatment of superficial basal cell carcinomas using topically applied delta-aminolaevulinic acid and a filtered xenon lamp , 1996, Archives of Dermatological Research.

[10]  T Poulsen,et al.  Photodynamic Therapy with Topical dL‐aminolevulinic Acid Delays UV Photocarcinogenesis in Hairless Mice , 1997, Photochemistry and photobiology.

[11]  R. Marks,et al.  Incidence of non-melanocytic skin cancer treated in Australia , 1988, British medical journal.

[12]  C. Whitehurst,et al.  Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid‐based photodynamic therapy , 2000, The British journal of dermatology.

[13]  Even Angell-Petersen,et al.  Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate. , 2006, The Journal of investigative dermatology.

[14]  H. Soyer,et al.  Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy. , 1998, Archives of dermatology.

[15]  H. Wulf,et al.  Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. , 2006, Acta dermato-venereologica.

[16]  Ann-Marie Wennberg.  Pain, pain relief and other practical issues in photodynamic therapy , 2005, The Australasian journal of dermatology.

[17]  H. Lui,et al.  Systemic photodynamic therapy with aminolaevulinic acid delays the appearance of ultraviolet‐induced skin tumours in mice , 2001, The British journal of dermatology.

[18]  E. Jeffes.  Levulan ® : the first approved topical photosensitizer for the treatment of actinic keratosis , 2002, The Journal of dermatological treatment.

[19]  H. Hönigsmann,et al.  Photodynamic therapy of epithelial skin tumours using delta‐aminolaevulinic acid and desferrioxamine , 1995, The British journal of dermatology.

[20]  Jean-Jacques Grob,et al.  Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. , 2004, Archives of dermatology.

[21]  M. Goldman,et al.  ALA/PDT in the treatment of actinic keratosis: spot versus confluent therapy , 2003, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

[22]  R. Bennett,et al.  Failure of curettage and electrodesiccation for removal of basal cell carcinoma. , 1984, Archives of dermatology.

[23]  B. Gilchrest,et al.  δ‐Aminolevulinic Acid and Blue Light Photodynamic Therapy for Treatment of Multiple Basal Cell Carcinomas in Two Patients with Nevoid Basal Cell Carcinoma Syndrome , 2004 .

[24]  G. Rennie,et al.  MALIGNANT TRANSFORMATION OF SOLAR KERATOSES TO SQUAMOUS CELL CARCINOMA , 1988, The Lancet.

[25]  C. Morton,et al.  Guidelines for the management of basal cell carcinoma , 2008, The British journal of dermatology.

[26]  Robert Bissonette,et al.  Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond. , 2004, Journal of drugs in dermatology : JDD.

[27]  C. Elmets,et al.  Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes. , 2004, Archives of dermatology.

[28]  P Lehmann,et al.  Preferential Relative Porphyrin Enrichment in Solar Keratoses upon Topical Application of ^‐Aminolevulinic Acid Methylester , 1998, Photochemistry and photobiology.

[29]  A. Oseroff,et al.  Basal cell and squamous cell skin cancers. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

[30]  P. Macdonald,et al.  Skin cancer in Australian heart transplant recipients. , 1999, Journal of the American Academy of Dermatology.

[31]  K. Giercksky,et al.  A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. , 2001, The British journal of dermatology.

[32]  K. thestrup-pedersen,et al.  Morbus Bowen. A description of the disease in 617 patients. , 1988, Acta dermato-venereologica.

[33]  G. Kao.  Carcinoma arising in Bowen's disease. , 1986, Archives of dermatology.

[34]  F. J. Ensell,et al.  ATMOSPHERIC OZONE AND FEMORAL FRACTURES , 1975, The Lancet.

[35]  A. Berner,et al.  Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. , 1999, Acta dermato-venereologica.

[36]  H. Wulf,et al.  Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment , 2003, The British journal of dermatology.

[37]  C. Whitehurst,et al.  Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease , 1996, The British journal of dermatology.

[38]  R. Kelly,et al.  Low density lipoprotein receptor and cation-independent mannose 6- phosphate receptor are transported from the cell surface to the Golgi apparatus at equal rates in PC12 cells , 1992, The Journal of cell biology.

[39]  F. Gad,et al.  Photodynamic Therapy with 5-Aminolevulinic Acid Induces Apoptosis and Caspase Activation in Malignant T Cells , 2001, Journal of cutaneous medicine and surgery.

[40]  C. Morton,et al.  Randomized comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease , 2003, The British journal of dermatology.

[41]  S Hansen,et al.  Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. , 1999, Journal of the American Academy of Dermatology.

[42]  D. Piacquadio,et al.  Short incubation PDT versus 5-FU in treating actinic keratoses. , 2003, Journal of drugs in dermatology : JDD.

[43]  R. Stern,et al.  Incidence of skin cancer in 5356 patients following organ transplantation , 2000, The British journal of dermatology.

[44]  Michele T. Cooper,et al.  Photodynamic therapy for the treatment of basal cell carcinoma. , 1992, Archives of dermatology.

[45]  Hans Christian Wulf,et al.  Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin. , 2003, Archives of dermatology.

[46]  R. Dawber,et al.  Treatment of cutaneous Bowen's disease with particular emphasis on the problem of lower leg lesions , 1998, The Australasian journal of dermatology.

[47]  M A Weinstock,et al.  Nonmelanoma skin cancer in the United States: incidence. , 1994, Journal of the American Academy of Dermatology.

[48]  L. Schouten,et al.  A systematic review of treatment modalities for primary basal cell carcinomas. , 1999, Archives of dermatology.

[49]  K. Kuželová,et al.  Early apoptotic features of K562 cell death induced by 5-aminolaevulinic acid-based photodynamic therapy. , 2004, Journal of photochemistry and photobiology. B, Biology.

[50]  C. Whitehurst,et al.  Comparison of red and green light in the treatment of Bowen’s disease by photodynamic therapy , 2000, The British journal of dermatology.

[51]  J E Hewett,et al.  Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective. , 1991, Archives of dermatology.

[52]  D. Murrell,et al.  A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix®) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study , 2003, The Journal of dermatological treatment.

[53]  E. Jeffes,et al.  Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. , 2004, Archives of dermatology.

[54]  P Baas,et al.  Photodynamic therapy with meta‐tetrahydroxyphenylchlorin for basal cell carcinoma: a phase I/II study , 2001, The British journal of dermatology.

[55]  T. Mang,et al.  Photodynamic therapy in the treatment of Bowen's disease. , 1992, Journal of the American Academy of Dermatology.

[56]  M. Turner,et al.  Guidelines of care for basal cell carcinoma. The American Academy of Dermatology Committee on Guidelines of Care. , 1992, Journal of the American Academy of Dermatology.

[57]  B. Hanusa,et al.  New primary nonmelanoma skin cancer in patients with a history of squamous cell carcinoma of the skin. Implications and recommendations for follow-up. , 1992, Journal of the American Academy of Dermatology.

[58]  R. Glogau.  The risk of progression to invasive disease. , 2000, Journal of the American Academy of Dermatology.

[59]  Morton,et al.  Guidelines for management of Bowen's disease , 1999, The British journal of dermatology.

[60]  M. Alexiades-Armenakas,et al.  Laser-mediated photodynamic therapy of actinic keratoses. , 2003, Archives of dermatology.

[61]  M. Landthaler,et al.  Non-oncologic indications for ALA-PDT , 2002, The Journal of dermatological treatment.

[62]  Q. Peng,et al.  Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX. , 1996, British Journal of Cancer.

[63]  C. Grin,et al.  Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation. , 1991, The Journal of dermatologic surgery and oncology.

[64]  R. M. Szeimiesa,et al.  Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. , 2002 .

[65]  P. Seed,et al.  A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. , 1999, Journal of the American Academy of Dermatology.

[66]  K. Svanberg,et al.  A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. , 2005, Acta dermato-venereologica.

[67]  R. Bissonnette,et al.  Multiple large surface photodynamic therapy sessions with topical methylaminolaevulinate in PTCH heterozygous mice , 2005, The British journal of dermatology.

[68]  A. Lucky,et al.  Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. , 2003, Journal of the American Academy of Dermatology.

[69]  S. H. Fox,et al.  The risk of developing subsequent nonmelanoma skin cancers. , 1990, Journal of the American Academy of Dermatology.

[70]  J. Moan,et al.  Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in mice , 2002, Archives of Dermatological Research.

[71]  J. Vandenbroucke,et al.  Incidence of skin cancer after renal transplantation in The Netherlands. , 1990, Transplantation.

[72]  R. Hirose,et al.  Skin Cancer as a Contraindication to Organ Transplantation , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[73]  B. O'Sullivan,et al.  The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. , 1996, Transplantation.

[74]  Telfer Nr,et al.  Guidelines for the management of basal cell carcinoma. British Association of Dermatologists. , 1999 .

[75]  P. Calzavara-Pinton,et al.  Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. , 1995, Journal of photochemistry and photobiology. B, Biology.

[76]  Joachim Mühling,et al.  Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck , 1999, Lasers in surgery and medicine.

[77]  K Svanberg,et al.  Photodynamic therapy of non‐melanoma malignant tumours of the skin using topical δ‐amino levulinic acid sensitization and laser irradiation , 1994, The British journal of dermatology.

[78]  T. Ruzicka,et al.  Photodynamic therapy in dermatology. , 1998, Archives of dermatology.

[79]  J. Kennedy,et al.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.

[80]  L. Naldi,et al.  The epidemiology of skin cancer , 2002, The British journal of dermatology.